Shire plc (ADR) (NASDAQ:SHPG)

CAPS Rating: 2 out of 5

A pharmaceutical company that focuses on meeting the needs of the specialist physician.

Recs

1
Player Avatar TMFBiologyFool (97.16) Submitted: 1/7/2009 6:31:18 PM : Underperform Start Price: $46.93 SHPG Score: +11.58

Adderall faces generic competition in April and getting patients to switch to Vyvanse will be difficult.

Featured Broker Partners


Advertisement